The American Psychiatric Publishing textbook of psychopharmacology

The American Psychiatric Publishing textbook of psychopharmacology / edited by Alan F. Schatzberg, Charles B. Nemeroff.

Saved in:
Bibliographic Details
Other Authors: Schatzberg, Alan F., Nemeroff, Charles B.
Format: Book
Language:English
Published: Washington, DC : American Psychiatric Pub., c2004.
Edition:3rd ed.
Subjects:
Mental illness > Chemotherapy.
Psychotropic drugs.
Psychopharmacology.
Table of Contents:
  • Ch. 1. Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders
  • Ch. 2. Basic principles of molecular biology and genomics
  • Ch. 3. Chemical neuroanatomy of the primate brain
  • Ch. 4. Electrophysiology
  • Ch. 5. Animal models
  • Ch. 6. Psychoneuroendocrinology
  • Ch. 7. Principles of pharmacokinetics and pharmacodynamics
  • Ch. 8. Brain-immune system interactions: relevance to the pathophysiology and treatment of neuropsychiatric disorders
  • Ch. 9. Brain imaging in psychopharmacology
  • Ch. 10. Statistics and clinical trial design in psychopharmacology
  • Ch. 11. Pharmacoeconomics
  • Ch. 12. Tricyclic and tetracyclic drugs
  • Ch. 13. Fluoxetine
  • Ch. 14. Sertraline
  • Ch. 15. Paroxetine
  • Ch. 16. Fluvoxamine
  • Ch. 17. Citalopram and s-citalopram
  • Ch. 18. Monoamine oxidase inhibitors
  • Ch. 19. Trazodone and nefazodone
  • Ch. 20. Bupropion
  • Ch. 21. Mirtazapine
  • Ch. 22. Venlafaxine
  • Ch. 23. Duloxetine and milnacipran
  • Ch. 24. Benzodiazepines
  • Ch. 25. Buspirone and gepirone
  • Ch. 26. Investigational treatments for mood and anxiety disorders: CRH receptor antagonists, NK-1 receptor antagonists, and glucocorticoid receptor antagonists
  • Ch. 27. Classic antipsychotic medications
  • Ch. 28. Clozapine
  • Ch. 29. Olanzapine
  • Ch. 30. Quetiapine
  • Ch. 31. Aripiprazole
  • Ch. 32. Risperidone
  • Ch. 33. Ziprasidone
  • Ch. 34. Drugs to treat extrapyramidal side effects
  • Ch. 35. Lithium
  • Ch. 36. Valproate
  • Ch. 37. Carbamazepine and oxcarbazepine
  • Ch. 38. Gabapentin
  • Ch. 39. Lamotrigine
  • Ch. 40. Topiramate
  • Ch. 41. Cognitive enhancers
  • Ch. 42. Sedative-hypnotics
  • Ch. 43. Psychostimulants in psychiatry: amphetamine, methylphenidate, and modafinil
  • Ch. 44. Electroconvulsive therapy
  • Ch. 45. Biology of mood disorders
  • Ch. 46. Neurobiology of schizophrenia
  • Ch. 47. Neurobiology of anxiety disorders
  • Ch. 48. Biology of Alzheimer's Disease
  • Ch. 49. Neurobiology of substance abuse disorders
  • Ch. 50. Biology of eating disorders
  • Ch. 51. Biology of personality disorders
  • Ch. 52. Treatment of depression
  • Ch. 53. Treatment of bipolar disorder
  • Ch. 54. Treatment of schizophrenia
  • Ch. 55. Treatment of anxiety disorders
  • Ch. 56. Management of noncognitive symptoms of dementia: behavioral and psychological symptoms of dementia
  • Ch. 57. Treatment of childhood and adolescent disorders
  • Ch. 58. Treatment of substance-related disorders
  • Ch. 59. Treatment of eating disorders
  • Ch. 60. Treatment of agitation and aggression in the elderly
  • Ch. 61. Treatment of personality disorders
  • Ch. 62. Psychiatric emergencies
  • Ch. 63. Treatment during late life
  • Ch. 64. Psychopharmacology during pregnancy and lactation
  • Ch. 65. Treatment of insomnia.

Similar Items